← All stocks

LEMAITRE VASCULAR INC

LMAT Net selling

CIK 0001158895 #2093 in the set updated 17 Sep 2026

Bought (120 mo)

$205.26K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$206.97M

$45.35M on a plan · $53.44M straight out of an exercise

Sold at will

$108.18M

173 of 279 sales

Net

−$206.76M

−$107.98M against sales at will

By person

13 insiders · 369 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

LeMaitre George W

Chairman and CEO

—

$155.26M (149)

−$155.26M

1,513,419

6.62%

$161.93M

−57.3%

Pellegrino Joseph P JR

Director

—

$17.40M (36) scheduled

−$17.40M

15,021

0.0657%

$1.61M

−87.0%

Roberts David B

President and Director

$200.51K (1)

$16.57M (30) scheduled

−$16.37M

14,667

0.0641%

$1.57M

−80.1%

Kamke Trent G

Senior V. P., Operations

—

$6.40M (23)

−$6.40M

3,749

0.0164%

$401.13K

−78.9%

Roush John A

Director

$4.75K (2)

$3.16M (9) scheduled

−$3.16M

7,748

0.0339%

$829.01K

+4,181%

Jasinski Lawrence J

Director

—

$3.07M (14) scheduled

−$3.07M

4,714

0.0206%

$504.38K

−57.2%

Ross Bridget A

Director

—

$2.58M (7) scheduled

−$2.58M

3,942

0.0172%

$421.78K

—

Gebauer Peter R

President, International OP

—

$1.28M (5) scheduled

−$1.28M

2,253

0.0099%

$241.06K

−85.3%

Thomas Michael H

Director

—

$1.04M (3) scheduled

−$1.04M

0.0000%

$0.00

—

SHADAN MARTHA

Director

—

$151.55K (2) scheduled

−$151.55K

2,962

0.0130%

$316.92K

—

Wijas Michael T

VP of Sales, The Americas

—

$73.72K (1) scheduled

−$73.72K

1,238

0.0054%

$132.46K

0.0%

O'Connor John James

Director

—

62,827

0.2747%

$6.72M

+8.2%

LeBlanc Dorian Paul

Chief Financial Officer

—

2,302

0.0101%

$246.31K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Roush John A

26 Aug 2020

Director

Buy indirect

$31.06

$931.73

Roberts David B

14 Aug 2020

President and Director

Buy

7,074

$28.35

$200.51K

Roush John A

21 May 2020

Director

Buy indirect

151

$25.28

$3.82K

Showing 250 of 369 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 681

Amendments (4/A) skipped 18

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 15

Sales straight out of an exercise 91

Sales at will 173

Transactions with no price 0

Shares from compensation/vesting 2,291,602

Sales filed before the plan box existed 138

History held since 31 Aug 2016